Stay updated on Emricasan for Decompensated NASH Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page.

Latest updates to the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page
- Check6 days agoChange DetectedSteatotic Liver Disease has been added to the glossary to reflect updated terminology for liver fat-related conditions used on this study page. Fatty Liver Disease has been removed from the glossary.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page's revision label updates from v3.6.2 to v3.6.3, indicating a small platform/template update rather than changes to study information.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page now displays the updated Revision: v3.6.2, replacing the prior Revision: v3.6.0.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page adds new help/navigation links (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision label to v3.6.0; metadata labels are standardized (Last Verified, Last Known Status Was) and the Intervention/Treatment heading is reformatted.SummaryDifference0.9%

- Check48 days agoChange DetectedThe page footer now shows Revision: v3.5.5, replacing the previous v3.5.4. This reflects a new build of the page.SummaryDifference0.0%

- Check70 days agoChange Detected- The page now shows Revision: v3.5.4, replacing the prior v3.5.3, indicating a deployed update to the page. The study details and content remain unchanged.SummaryDifference0.0%

Stay in the know with updates to Emricasan for Decompensated NASH Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page.